Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter, Randomized, Masked, Placebo-Controlled Trial to Assess the Safety and Efficacy of Lucinactant in Acute Hypoxemic Respiratory Failure in Children Up to Two Years of Age

NCT00578734 is registered in ClinicalTrials.gov with Windtree Therapeutics as lead sponsor.

NCT NCT00578734
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00578734 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter, Randomized, Masked, Placebo-Controlled Trial to Assess the Safety and Efficacy of Lucinactant in Acute Hypoxemic Respiratory Failure in Children Up to Two Years of Age
Lead sponsor
Windtree Therapeutics
Phase
Phase 2
Overall status
Completed
Start date
June 30, 2007
Completion date
April 30, 2010
Enrollment
165 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

acute hypoxemic respiratory failure